Compositions and methods for inducing conformational changes in cereblon and other E3… Grant US-11733233-B2 United States of America 22 Aug 2023
Compositions and methods for inducing conformational changes in cereblon and other E3… Grant US-11419861-B2 United States of America 23 Aug 2022
Compositions and methods for inducing conformational changes in cereblon and other E3… Grant US-10830762-B2 United States of America 10 Nov 2020
Compositions and methods for inducing conformational changes in cereblon and other E3… Grant US-10668057-B2 United States of America 02 Jun 2020
Compositions and methods for inducing conformational changes in cereblon and other E3… Grant US-10092555-B2 United States of America 09 Oct 2018
Methods for the treatment of cancer and inflammatory diseases using cereblon as a… Grant US-10047151-B2 United States of America 14 Aug 2018
MEANS TO TREAT MYELOMAS WHICH ARE RESISTANT TO THALIDOMIDE, LENALIDOMIDE OR POMALIDOMIDE Application EP-3266452-A1 European Patent Office 10 Jan 2018
Methods for determining drug efficacy using cereblon-associated proteins Grant US-9857359-B2 United States of America 02 Jan 2018
Methods and materials for assessing responsiveness to lenalidomide, thalidomide, and/or… Grant US-9662319-B2 United States of America 30 May 2017
Pharmaceutical composition containing core factor involved in proliferation and… Grant US-9611465-B2 United States of America 04 Apr 2017
METHODS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES USING CEREBLON AS A… Application EP-3096142-A3 European Patent Office 08 Mar 2017
Cereblon isoforms and their use as biomarkers for therapeutic treatment Grant US-9587281-B2 United States of America 07 Mar 2017
Methods for the treatment of cancer and inflammatory diseases using cereblon as a… Grant US-9365640-B2 United States of America 14 Jun 2016
METHODS AND MATERIALS FOR ASSESSING RESPONSIVENESS TO LENALIDOMIDE, THALIDOMIDE, AND/OR… Application EP-2683412-A4 European Patent Office 29 Jan 2014
METHODS AND MATERIALS FOR ASSESSING RESPONSIVENESS TO LENALIDOMIDE, THALIDOMIDE, AND/OR… Application EP-2683412-A2 European Patent Office 15 Jan 2014
METHODS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES USING CEREBLON AS A… Application WO-2012149299-A3 World Intellectual Property Organisation (WIPO) 27 Jun 2013